Titre : Tumeurs du thorax

Tumeurs du thorax : Questions médicales fréquentes

Termes MeSH sélectionnés :

Contraception Behavior
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs du thorax : Questions médicales les plus fréquentes", "headline": "Tumeurs du thorax : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs du thorax : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-21", "dateModified": "2025-03-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs du thorax" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs par siège", "url": "https://questionsmedicales.fr/mesh/D009371", "about": { "@type": "MedicalCondition", "name": "Tumeurs par siège", "code": { "@type": "MedicalCode", "code": "D009371", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adénocarcinome pulmonaire", "alternateName": "Adenocarcinoma of Lung", "url": "https://questionsmedicales.fr/mesh/D000077192", "about": { "@type": "MedicalCondition", "name": "Adénocarcinome pulmonaire", "code": { "@type": "MedicalCode", "code": "D000077192", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.894.797.520.055" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adénocarcinome bronchioloalvéolaire", "alternateName": "Adenocarcinoma, Bronchiolo-Alveolar", "url": "https://questionsmedicales.fr/mesh/D002282", "about": { "@type": "MedicalCondition", "name": "Adénocarcinome bronchioloalvéolaire", "code": { "@type": "MedicalCode", "code": "D002282", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.894.797.520.055.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Blastome pulmonaire", "alternateName": "Pulmonary Blastoma", "url": "https://questionsmedicales.fr/mesh/D018202", "about": { "@type": "MedicalCondition", "name": "Blastome pulmonaire", "code": { "@type": "MedicalCode", "code": "D018202", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.894.797.520.867" } } }, { "@type": "MedicalWebPage", "name": "Tumeurs fibreuses solitaires de la plèvre", "alternateName": "Solitary Fibrous Tumor, Pleural", "url": "https://questionsmedicales.fr/mesh/D054363", "about": { "@type": "MedicalCondition", "name": "Tumeurs fibreuses solitaires de la plèvre", "code": { "@type": "MedicalCode", "code": "D054363", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.894.797.640.800" } } } ], "about": { "@type": "MedicalCondition", "name": "Tumeurs du thorax", "alternateName": "Thoracic Neoplasms", "code": { "@type": "MedicalCode", "code": "D013899", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yan Wang", "url": "https://questionsmedicales.fr/author/Yan%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China." } }, { "@type": "Person", "name": "Naseema Gangat", "url": "https://questionsmedicales.fr/author/Naseema%20Gangat", "affiliation": { "@type": "Organization", "name": "Mayo Clinic, Rochester, MN, USA." } }, { "@type": "Person", "name": "Anja C Roden", "url": "https://questionsmedicales.fr/author/Anja%20C%20Roden", "affiliation": { "@type": "Organization", "name": "Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN." } }, { "@type": "Person", "name": "Marianne Pavel", "url": "https://questionsmedicales.fr/author/Marianne%20Pavel", "affiliation": { "@type": "Organization", "name": "Department of Medicine, University Hospital Erlangen, Erlangen, Germany." } }, { "@type": "Person", "name": "Dermot O'Toole", "url": "https://questionsmedicales.fr/author/Dermot%20O%27Toole", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Determinants of unmet need for modern contraceptives in Ethiopia.", "datePublished": "2024-05-01", "url": "https://questionsmedicales.fr/article/38692721", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-079477" } }, { "@type": "ScholarlyArticle", "name": "Is the Decision Not to Use Contraception an Indicator of Reproductive Agency?", "datePublished": "2023-02-15", "url": "https://questionsmedicales.fr/article/36790883", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/sifp.12235" } }, { "@type": "ScholarlyArticle", "name": "Meeting Preferences for Specific Contraceptive Methods: An Overdue Indicator.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36705876", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/sifp.12218" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of and factors associated with contraceptive discontinuation in Kenya.", "datePublished": "2022-05-24", "url": "https://questionsmedicales.fr/article/35695442", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4102/phcfm.v14i1.2992" } }, { "@type": "ScholarlyArticle", "name": "Reasons for modern contraceptives choice and long-acting reversible contraceptives early removal in Amhara Region, Northwest Ethiopia; qualitative approach.", "datePublished": "2023-05-19", "url": "https://questionsmedicales.fr/article/37208658", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12905-023-02375-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://questionsmedicales.fr/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs par siège", "item": "https://questionsmedicales.fr/mesh/D009371" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs du thorax", "item": "https://questionsmedicales.fr/mesh/D013899" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs du thorax - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs du thorax", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs du thorax", "description": "Comment diagnostiquer une tumeur thoracique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés aux tumeurs thoraciques ?\nQuelle est l'importance de l'histologie ?\nLes examens génétiques sont-ils utiles ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Contraception+Behavior&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs du thorax", "description": "Quels sont les symptômes courants des tumeurs thoraciques ?\nLa perte de poids est-elle un symptôme ?\nLes tumeurs thoraciques causent-elles des saignements ?\nComment la fatigue se manifeste-t-elle ?\nLes symptômes varient-ils selon le type de tumeur ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Contraception+Behavior&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs du thorax", "description": "Comment prévenir les tumeurs thoraciques ?\nLe dépistage est-il utile ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique aide-t-il à prévenir ?\nLes vaccinations sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Contraception+Behavior&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs du thorax", "description": "Quels traitements sont disponibles pour les tumeurs thoraciques ?\nLa chirurgie est-elle toujours nécessaire ?\nQu'est-ce que la chimiothérapie néoadjuvante ?\nLa radiothérapie est-elle efficace ?\nY a-t-il des traitements ciblés disponibles ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Contraception+Behavior&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs du thorax", "description": "Quelles complications peuvent survenir ?\nLes tumeurs thoraciques peuvent-elles causer des douleurs ?\nComment les tumeurs affectent-elles la respiration ?\nLes tumeurs peuvent-elles provoquer des caillots sanguins ?\nQuelles sont les complications post-chirurgicales ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Contraception+Behavior&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs du thorax", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'exposition professionnelle est-elle un facteur ?\nLe mode de vie influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Contraception+Behavior&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur thoracique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (radiographie, scanner) et biopsie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la tomodensitométrie, l'IRM et la bronchoscopie." } }, { "@type": "Question", "name": "Quels marqueurs tumoraux sont associés aux tumeurs thoraciques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs comme le CEA et le CA 125 peuvent être utilisés pour le suivi." } }, { "@type": "Question", "name": "Quelle est l'importance de l'histologie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'histologie permet de déterminer le type de tumeur et son agressivité." } }, { "@type": "Question", "name": "Les examens génétiques sont-ils utiles ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à identifier des mutations spécifiques pour le traitement ciblé." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs thoraciques ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la toux persistante, la douleur thoracique et l'essoufflement." } }, { "@type": "Question", "name": "La perte de poids est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la perte de poids inexpliquée peut être un signe de tumeur thoracique." } }, { "@type": "Question", "name": "Les tumeurs thoraciques causent-elles des saignements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des hémoptysies, c'est-à-dire des saignements dans les voies respiratoires." } }, { "@type": "Question", "name": "Comment la fatigue se manifeste-t-elle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La fatigue peut être persistante et s'aggraver avec l'évolution de la maladie." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tumeur ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type et la localisation de la tumeur." } }, { "@type": "Question", "name": "Comment prévenir les tumeurs thoraciques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et l'exposition à des agents cancérigènes aide à prévenir." } }, { "@type": "Question", "name": "Le dépistage est-il utile ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce peut aider à détecter les tumeurs à un stade précoce." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut réduire le risque de développer des tumeurs." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut contribuer à réduire le risque de cancer." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations, comme contre le HPV, peuvent réduire le risque de cancers associés." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs thoraciques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, la chirurgie dépend du stade et de la localisation de la tumeur." } }, { "@type": "Question", "name": "Qu'est-ce que la chimiothérapie néoadjuvante ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "C'est un traitement administré avant la chirurgie pour réduire la taille de la tumeur." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée pour traiter les tumeurs non opérables ou en complément." } }, { "@type": "Question", "name": "Y a-t-il des traitements ciblés disponibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des thérapies ciblées sont disponibles pour certains types de tumeurs spécifiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la métastase, l'infection et l'insuffisance respiratoire." } }, { "@type": "Question", "name": "Les tumeurs thoraciques peuvent-elles causer des douleurs ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des douleurs thoraciques dues à la pression sur les nerfs." } }, { "@type": "Question", "name": "Comment les tumeurs affectent-elles la respiration ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent obstruer les voies respiratoires, entraînant des difficultés respiratoires." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles provoquer des caillots sanguins ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent augmenter le risque de thrombose veineuse profonde." } }, { "@type": "Question", "name": "Quelles sont les complications post-chirurgicales ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des infections, des saignements et des problèmes respiratoires." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à l'amiante et les antécédents familiaux sont des facteurs clés." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de tumeurs thoraciques augmente avec l'âge." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer augmentent le risque de développer des tumeurs thoraciques." } }, { "@type": "Question", "name": "L'exposition professionnelle est-elle un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines professions exposent à des substances cancérigènes, augmentant le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } } ] } ] }

Sources (10000 au total)

Determinants of unmet need for modern contraceptives in Ethiopia.

To identify the determinants of the unmet need for modern contraceptives in Ethiopia.... Community-based cross-sectional study.... Ethiopia.... A group of 6636 women of reproductive age (15-49 years) who were sexually active were included in the study.... Unmet need for modern contraceptives METHOD: The study used data from the 2019 Performance Monitoring for Action-Ethiopia survey, which was community-based and cross-sectional. The sample consisted of... The proportion of unmet need for modern contraceptives was 19.7% (95% CI: 18% to 21.5%). Women with supportive norms towards family planning had a lower risk of unmet need for spacing (relative risk r... High levels of unmet need for modern contraceptives were observed in Ethiopia, showing geographical variations. It is essential to address the key factors affecting women and work towards reducing dis...

Prevalence of and factors associated with contraceptive discontinuation in Kenya.

The overwhelming uptake of contraception in Kenya at 58% suggests huge potential for a continued increase, but discontinuation threatens efforts to achieve new targets. Further increases in contracept... To establish the prevalence and factors associated with contraceptive discontinuation.... Kenya, with a successful family planning programme, but also the challenge of discontinuation rates of 31%.... Contraceptive calendar data from the 2014 Kenya Demographic and Health Survey were used in the survival analysis approach.... Overall discontinuation rates were 37% (24 months) and 74% at (36 months), whilst discontinuation in need was 36%. Side effects accounted for 40% of discontinuations, whilst injection and pill recorde... The study showed a close link between contraceptive method used and discontinuation and thus the need to address method-related issues in an attempt to minimise discontinuation in Kenya. Expanding con...

Reasons for modern contraceptives choice and long-acting reversible contraceptives early removal in Amhara Region, Northwest Ethiopia; qualitative approach.

Women use modern contraceptive methods, mainly either to limit or space pregnancy and both are not identical in their choices. One method may not best fit an individual's need irrespective of the time... A phenomenological study design was used to explore sampled women's reasons and experiences. Reproductive-aged women (15-49 years) who removed long-acting methods in the past 6 months were included. A... Several misconceptions about contraceptives (e.g., implants are not appropriate for daily laborers, women who use contraceptives (such as injectables) can only bear girl-child, etc.) were reported by ... Our study found different reasons and misconceptions for modern contraceptive methods' non-use and discontinuation. Standardized counseling approaches like the REDI (Rapport Building, Exploration, Dec...

Factors associated with postpartum contraceptive planning in New Zealand.

To identify factors associated with contraceptive planning in the immediate postpartum period.... Survey of those receiving inpatient postpartum care in two tertiary hospitals/associated birthing units (Auckland, New Zealand). Multivariable analyses using logistic regression examined independent p... Of 571 participants, those who recalled both antenatal and postpartum contraception discussions were more likely to have a contraceptive plan than those who recalled neither (aOR 5.6(2.8-11.5)).... Both antenatal and postpartum contraceptive discussions are associated with postpartum contraceptive planning.... Both antenatal and postpartum discussions around contraception were independently associated with increased rates of established contraceptive plan postpartum, however patients who recalled both were ...

Postpartum contraceptive choice and fulfillment in patients with opioid use disorder.

We examined the differences in postpartum contraception between patients with and without opioid use disorder (OUD).... We conducted a retrospective, single-institution, cohort analysis assessing differences in desired method of postpartum contraception and plan fulfillment.... Patients with OUD comprised 200/8654 (2.3%) of our study cohort. After 2:1 matching, method desired (matched odds ratio [mOR] 0.86, 95% confidence interval [CI] 0.60-1.23 for highly vs. moderately eff... Patients with and without OUD were similar in their choice and fulfillment of postpartum contraception....

Impact of Sociocultural Factors on Contraceptive Use: A Case Study of Pakistan.

The use of birth control methods is influenced by complex and competing socioeconomic and demographic factors. Regardless of the complexity of the behavioral approach of women, the utility of contrace... The study revealed a distinctive highly significant negative effect on contraceptive use and women's age. The odds ratio (OR) for women aged 25-34, 35-44, and above 44 was 1.242, 1.155, and 0.638, res... Our results indicated that contraceptive use is almost relevant to sociodemographic factors (education, age, language, partner, work, etc.). Women with no formal education living in rural areas were n...

Provider perspectives on adolescent access to contraception in South Africa.

Poor access to contraception influences adolescent health outcomes and may lead to sexual and reproductive health challenges. Unmet sexual and reproductive health should contribute to unplanned adoles... This study explored factors influencing adolescents' access to contraceptive methods from the perspective of primary healthcare providers in South Africa.... This study was conducted in two health districts of the Western Cape province in South Africa: the City of Cape Town Metropolitan Municipality and the West Coast district.... Using a qualitative research design, in-depth semi-structured interviews were conducted with 24 healthcare providers who work in primary healthcare clinics. Subsequently, the interviews were transcrib... Four themes emerged through the data analysis: (1) personal influences, (2) community-level influences, (3) health system influences, and (4) policy-level influences. Representative quotations were us... Adolescence is shaped by various influences that affect adolescents' ability to access contraception. These factors include their awareness of contraception, social environment, provider biases and sc...